MeSH term
Frequency | Condition_Probility | Humans | 16 | 0.0 |
*DNA Methylation | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Adult | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Female | 5 | 0.0 |
Glycoproteins/genetics/*metabolism | 2 | 5.0 |
Middle Aged | 3 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Animals | 5 | 0.0 |
Comparative Study | 2 | 0.0 |
Glycoproteins/*genetics | 2 | 1.0 |
Mice | 3 | 0.0 |
Aged | 2 | 0.0 |
Gene Silencing | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
*Zebrafish Proteins | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Up-Regulation | 3 | 0.0 |
Male | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Intercellular Signaling Peptides and Proteins/*genetics | 2 | 3.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
*Chromosomes, Human, Pair 8 | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
DNA Methylation | 2 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Proto-Oncogene Proteins/*antagonists & inhibitors | 2 | 8.0 |
Gene Expression Profiling | 2 | 0.0 |
